Sealantium Medical
Not specified, Israel· Est.
Innovative polymer‑fibrin sealant patch that delivers faster, cheaper hemostasis for open and laparoscopic surgery.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Innovative polymer‑fibrin sealant patch that delivers faster, cheaper hemostasis for open and laparoscopic surgery.
Surgical HemostasisTissue Sealing
Technology Platform
A biodegradable, non‑permeable polymeric film embedding fibrin sealant that provides rapid mechanical sealing and accelerates coagulation, usable in both open and minimally invasive surgery.
Opportunities
The $1 billion global surgical sealant market and growing demand for minimally invasive solutions provide a clear path for rapid adoption of sFilm‑FS™ across multiple surgical specialties.
Risk Factors
Regulatory approval timelines, manufacturing scale‑up challenges, and competition from established fibrin patches such as TachoSil could delay commercial launch.
Competitive Landscape
Key competitors include TachoSil, Coseal, and Evicel; Sealantium differentiates itself with a foldable polymer film that enables faster sealing, lower fibrin usage, and applicability in laparoscopic procedures.